DK1045906T3 - APO-2-ligand - Google Patents
APO-2-ligandInfo
- Publication number
- DK1045906T3 DK1045906T3 DK99903166T DK99903166T DK1045906T3 DK 1045906 T3 DK1045906 T3 DK 1045906T3 DK 99903166 T DK99903166 T DK 99903166T DK 99903166 T DK99903166 T DK 99903166T DK 1045906 T3 DK1045906 T3 DK 1045906T3
- Authority
- DK
- Denmark
- Prior art keywords
- ligand
- apo
- antibodies
- believed
- nucleic acid
- Prior art date
Links
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 title abstract 7
- 108700012411 TNFSF10 Proteins 0.000 title abstract 7
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US788698A | 1998-01-15 | 1998-01-15 | |
US6053398A | 1998-04-15 | 1998-04-15 | |
PCT/US1999/001039 WO1999036535A1 (en) | 1998-01-15 | 1999-01-15 | Apo-2 ligand |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1045906T3 true DK1045906T3 (da) | 2009-02-16 |
Family
ID=26677483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99903166T DK1045906T3 (da) | 1998-01-15 | 1999-01-15 | APO-2-ligand |
Country Status (13)
Country | Link |
---|---|
US (1) | US6740739B1 (da) |
EP (2) | EP1045906B1 (da) |
JP (2) | JP2002508962A (da) |
AT (1) | ATE411385T1 (da) |
AU (1) | AU2325199A (da) |
CA (1) | CA2318029C (da) |
CY (1) | CY1108681T1 (da) |
DE (1) | DE69939732D1 (da) |
DK (1) | DK1045906T3 (da) |
ES (1) | ES2316182T3 (da) |
HK (1) | HK1032603A1 (da) |
PT (1) | PT1045906E (da) |
WO (1) | WO1999036535A1 (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284236B1 (en) | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
US20040047864A1 (en) * | 1996-03-14 | 2004-03-11 | Human Genome Sciences, Inc. | Apoptosis inducing molecule I |
EP1820860A3 (en) * | 1999-06-02 | 2008-03-19 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
IL147029A0 (en) * | 1999-06-28 | 2002-08-14 | Genentech Inc | Method for making apo-2 ligand using divalent metal ions |
JP2005508162A (ja) * | 2001-10-02 | 2005-03-31 | ジェネンテック・インコーポレーテッド | Apo−2リガンド変異体とその使用法 |
PT1450847E (pt) | 2001-11-13 | 2011-01-05 | Genentech Inc | Formulações de ligando de apo2/trail e suas utilizações |
US7741285B2 (en) | 2001-11-13 | 2010-06-22 | Genentech, Inc. | APO-2 ligand/trail formulations |
CN1313611C (zh) * | 2002-02-22 | 2007-05-02 | 中国人民解放军第二军医大学 | 新型肿瘤凋亡素2配体基因、其表达的肿瘤凋亡素及其制法 |
AU2003247609A1 (en) * | 2002-06-24 | 2004-01-06 | Genentech, Inc. | Apo-2 ligand/trail variants and uses thereof |
GB0328261D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Groningen | Improved cytokine design |
US20080242603A1 (en) * | 2004-02-20 | 2008-10-02 | Yan Wang | Novel Apo2L and IL-24 Polypeptides, Polynucleotides, and Methods of Their Use |
CA2575152A1 (en) * | 2004-08-06 | 2006-02-16 | Genentech, Inc. | Method for predicting sensitivity of mammalian cells to apo2l/trail comprising deletion of biomarker expression |
AU2012200601B2 (en) * | 2004-08-06 | 2012-10-11 | Genentech, Inc. | Assays and methods using biomarkers |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
US8029783B2 (en) | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
WO2008061377A1 (en) * | 2006-11-22 | 2008-05-29 | Centre Hospitalier De L'universite De Montreal | Novel receptor for cd40l and uses thereof |
GB0724532D0 (en) * | 2007-12-17 | 2008-01-30 | Nat Univ Ireland | Trail variants for treating cancer |
WO2011043835A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Polypeptides that bind il-23r |
CA2812057A1 (en) | 2010-09-28 | 2012-04-05 | Kahr Medical Ltd. | Compositions and methods for treatment of hematological malignancies |
US20140178398A1 (en) | 2011-05-03 | 2014-06-26 | Genentech, Inc | Vascular disruption agents and uses thereof |
CN103534273B (zh) | 2011-09-16 | 2020-05-12 | 北京沙东生物技术有限公司 | 环化变构trail/apo2l及其编码基因与应用 |
EP2684896A1 (en) | 2012-07-09 | 2014-01-15 | International-Drug-Development-Biotech | Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof |
US20160067337A1 (en) | 2013-03-14 | 2016-03-10 | Bristol-Myers Squibb Company | Combination of dr5 agonist and anti-pd-1 antagonist and methods of use |
US9914761B2 (en) | 2014-07-10 | 2018-03-13 | Washington University | Oligomers for TNF superfamily inhibition |
CA3007031A1 (en) | 2015-12-01 | 2017-06-08 | Genmab B.V. | Anti-death receptor antibodies and methods of use thereof |
RU2769513C2 (ru) | 2017-01-05 | 2022-04-01 | Кахр Медикал Лтд. | Слитый белок pd1-4-1bbl и способы его применения |
WO2018127918A1 (en) | 2017-01-05 | 2018-07-12 | Kahr Medical Ltd. | A sirp alpha-cd70 fusion protein and methods of use thereof |
SI3565828T1 (sl) | 2017-01-05 | 2022-04-29 | Kahr Medical Ltd. | SIRP1 alfa-41BBL fuzijski protein in postopki za njegovo uporabo |
US11566060B2 (en) | 2017-01-05 | 2023-01-31 | Kahr Medical Ltd. | PD1-CD70 fusion protein and methods of use thereof |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3691016A (en) | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
CA1023287A (en) | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4195128A (en) | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
US4330440A (en) | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4229537A (en) | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
IL75318A (en) | 1984-05-31 | 1994-08-26 | Genentech Inc | Recombinant human memotoxin and methods for its recombinant production |
US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
JPS63502716A (ja) | 1986-03-07 | 1988-10-13 | マサチューセッツ・インステチュート・オブ・テクノロジー | 糖タンパク安定性の強化方法 |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
JP2755395B2 (ja) | 1987-09-23 | 1998-05-20 | ブリストル―マイアーズ スクイブ コムパニー | Hiv感染細胞に殺作用する抗体異種結合体 |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
EP0321196A3 (en) | 1987-12-18 | 1990-07-18 | Mycogen Plant Science, Inc. | 780 t-dna gene transcription activator |
WO1989005859A1 (en) | 1987-12-21 | 1989-06-29 | The Upjohn Company | Agrobacterium mediated transformation of germinating plant seeds |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
DK168302B1 (da) | 1989-06-29 | 1994-03-07 | Danisco | Fremgangsmåde til indføring af molekyler, især genetisk materiale i planteceller |
DK0479909T3 (da) | 1989-06-29 | 1997-04-07 | Medarex Inc | Bispecifikke reagenser til AIDS-behandling |
DE59010933D1 (de) | 1989-09-12 | 2003-05-08 | Hoffmann La Roche | TFN-bindende Proteine |
EP0502036B1 (en) | 1989-11-22 | 1995-12-20 | Genentech, Inc. | Latency associated peptide and uses therefor |
US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
JPH06507398A (ja) | 1991-05-14 | 1994-08-25 | リプリジェン コーポレーション | Hiv感染治療のための異種複合抗体 |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
ATE149570T1 (de) | 1992-08-17 | 1997-03-15 | Genentech Inc | Bispezifische immunoadhesine |
ATE157100T1 (de) | 1993-06-03 | 1997-09-15 | Therapeutic Antibodies Inc | Antikoerperfragmente in therapie |
JPH09503672A (ja) | 1993-10-14 | 1997-04-15 | イミュネックス・コーポレーション | Fas拮抗剤とその利用 |
AU7983294A (en) | 1993-10-19 | 1995-05-08 | Regents Of The University Of Michigan, The | P53-mediated apoptosis |
IL111125A0 (en) | 1994-05-11 | 1994-12-29 | Yeda Res & Dev | Soluble oligomeric tnf/ngf super family ligand receptors and their use |
NZ311982A (en) | 1995-06-29 | 1999-08-30 | Immunex Corp | Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies |
US6284236B1 (en) * | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
US6030945A (en) * | 1996-01-09 | 2000-02-29 | Genentech, Inc. | Apo-2 ligand |
WO1997033899A1 (en) | 1996-03-14 | 1997-09-18 | Human Genome Sciences, Inc. | Apoptosis inducing molecule i |
AU3381097A (en) | 1996-06-07 | 1998-01-05 | Amgen, Inc. | Tumor necrosis factor-related polypeptide |
KR20020056565A (ko) | 2000-12-29 | 2002-07-10 | 황규언 | 인간유래 세포 소멸 인자와 그 수용체의 결합체인TRAIL-sDR5 결합체의 결정화에 의한 3차원 구조및 TRAIL 결실 돌연변이 단백질 |
WO2002069995A2 (en) | 2001-02-16 | 2002-09-12 | Medical College Of Georgia Research Institute, Inc. | Use of trail and antiprogestins for treating cancer |
-
1999
- 1999-01-15 JP JP2000540237A patent/JP2002508962A/ja not_active Withdrawn
- 1999-01-15 US US09/582,450 patent/US6740739B1/en not_active Expired - Lifetime
- 1999-01-15 DK DK99903166T patent/DK1045906T3/da active
- 1999-01-15 DE DE69939732T patent/DE69939732D1/de not_active Expired - Lifetime
- 1999-01-15 EP EP99903166A patent/EP1045906B1/en not_active Expired - Lifetime
- 1999-01-15 AU AU23251/99A patent/AU2325199A/en not_active Abandoned
- 1999-01-15 WO PCT/US1999/001039 patent/WO1999036535A1/en active Application Filing
- 1999-01-15 ES ES99903166T patent/ES2316182T3/es not_active Expired - Lifetime
- 1999-01-15 AT AT99903166T patent/ATE411385T1/de active
- 1999-01-15 CA CA002318029A patent/CA2318029C/en not_active Expired - Lifetime
- 1999-01-15 PT PT99903166T patent/PT1045906E/pt unknown
- 1999-01-15 EP EP08012755A patent/EP2017341A3/en not_active Withdrawn
-
2001
- 2001-03-31 HK HK01102353.6A patent/HK1032603A1/xx not_active IP Right Cessation
-
2008
- 2008-12-17 CY CY20081101467T patent/CY1108681T1/el unknown
-
2010
- 2010-07-02 JP JP2010151519A patent/JP2010246560A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2017341A3 (en) | 2009-04-08 |
US6740739B1 (en) | 2004-05-25 |
PT1045906E (pt) | 2009-01-27 |
EP2017341A2 (en) | 2009-01-21 |
EP1045906B1 (en) | 2008-10-15 |
DE69939732D1 (de) | 2008-11-27 |
CA2318029A1 (en) | 1999-07-22 |
WO1999036535A9 (en) | 2000-03-02 |
JP2002508962A (ja) | 2002-03-26 |
ATE411385T1 (de) | 2008-10-15 |
ES2316182T3 (es) | 2009-04-01 |
WO1999036535A1 (en) | 1999-07-22 |
JP2010246560A (ja) | 2010-11-04 |
AU2325199A (en) | 1999-08-02 |
EP1045906A1 (en) | 2000-10-25 |
HK1032603A1 (en) | 2001-07-27 |
CY1108681T1 (el) | 2014-04-09 |
CA2318029C (en) | 2009-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE362985T1 (de) | Apo-2 ligand | |
DK1045906T3 (da) | APO-2-ligand | |
LUC00121I1 (da) | ||
DE69838249D1 (de) | Anti-apo-2 antikörper | |
IS6322A (is) | Viðtaki APRIL (BCMA) og notkun hans | |
DK0988301T3 (da) | Imidazolylcykliske acetaler | |
TW200716745A (en) | Anti-TNF antibodies, compositions, methods and uses | |
DE69840413D1 (de) | Dna 19355 polypeptide, ein homolog des tumornekrosefaktors | |
DK1009817T3 (da) | RTD-receptor | |
ATE236983T1 (de) | Durch zelldichte stimulierte protein-tyrosin- phosphatasen | |
SATO | Development of PC Precast Slab Pavement Connected with Horn-Joints |